The Global Bio-imaging Market comprises medical imaging modalities such as X-ray, ultrasound, MRI, CT scan, EEG, PET, and SPECT. Bio-imaging aids in early disease detection and effective diagnosis by capturing internal body structures. It provides high-quality images of organs, soft tissues, and bones without using invasive procedures. Bio-imaging gives physicians a detailed anatomical view, helps develop treatment plans, and guides surgeries.
The Global Bio-imaging Market is estimated to be valued at US$ 5.74 BN in 2024 and is expected to exhibit a CAGR of 15.% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in the Global Bio-imaging Market are Bracco Imaging S.P.A, Bayer HealthCare Pharmaceuticals, Esaote S.p.A, Digirad Corporation, FONAR Corporation, GE Healthcare, Hologic Inc., Hitachi Medical Corporation, Lantheus Medical Imaging, Inc., Covidien Pharmaceuticals, Mindray Medical International Limited., Gamma Medica Inc., Samsung Medison Co., Ltd., and Philips Healthcare. Key players are focusing on product launches and enhancing their product portfolio to gain a competitive advantage in the market. For instance, in 2021, Philips launched Incisive CT imaging and intervention platform to transform radiology workflows.
The growing incidence of cancer, cardiovascular diseases, neurological disorders is fueling the demand for advanced bio-imaging modalities globally. Bio-imaging helps detect diseases in earlier stages and facilitate timely diagnosis and treatment. Furthermore, increasing investments by governments and private organizations in the healthcare sector promise Global Bio-imaging Market Size growth over the forecast period.
The global bio-imaging market is expanding rapidly with advancements in technology. Players are focusing on emerging economies for business expansion due to increasing healthcare expenditures. Further, rising awareness regarding benefits of early disease diagnosis will boost the bio-imaging market revenue in the coming years.
Market drivers
Rapid technological advancements are the primary driver propelling the global bio-imaging market forward. Manufacturers are developing innovative imaging systems with improved imaging capabilities. For instance, multi-modality imaging systems integrate modalities like PET-CT and SPECT-CT to offer anatomical and functional details simultaneously. Additionally, AI and machine learning integration enhance image quality. Automated image analysis powered by deep learning helps radiologists with early detection. Such developments increase adoption rates and fuel market revenue.
Get more insights, On Global Bio-imaging Market